Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

MLWORHD:LX

37.25 USD 0.16 0.43%

As of 00:59:30 ET on 03/04/2015.

Snapshot for BlackRock Global Funds - World Healthscience Fund (MLWORHD)

Year To Date: +4.97% 3-Month: +4.53% 3-Year: +28.04% 52-Week Range: 28.68 - 37.72
1-Month: +4.21% 1-Year: +20.87% 5-Year: +18.62% Beta vs NDWUHC: 1.02

Mutual Fund Chart for MLWORHD

No chart data available.
  • MLWORHD:LX 37.41
  • 1M
  • 1Y
Interactive MLWORHD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for MLWORHD

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: 11-12-2007 Telephone: 352-34-20-101
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrockinternational.com

Fundamentals for MLWORHD

NAV (on 2015-03-04) 37.25
Assets (M) (on 2015-01-30) 3,250.86
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 1,000.00

Dividends for MLWORHD

No dividends reported

Fees & Expenses for MLWORHD

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.06

Top Fund Holdings for MLWORHD

Filing Date: 01/30/2015
Name Position Value % of Total
Novartis AG 1,264,600 123,910,320 3.942%
Biogen Idec Inc 275,407 107,177,388 3.409%
Celgene Corp 882,808 105,195,401 3.346%
Merck & Co Inc 1,647,100 99,287,188 3.158%
UnitedHealth Group Inc 907,026 96,371,512 3.066%
Alexion Pharmaceuticals Inc 502,968 92,163,856 2.932%
Johnson & Johnson 907,800 90,907,092 2.892%
Amgen Inc 574,900 87,534,274 2.785%
Actavis plc 325,592 86,783,292 2.761%
Roche Holding AG 320,400 86,572,947 2.754%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil